These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8496428)

  • 1. Dapsone-associated agranulocytosis and severe anemia in a patient with leukocytoclastic vasculitis.
    Woodbury GR; Fried W; Ertle JO; Malkinson FD
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):781-3. PubMed ID: 8496428
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant granulocyte colony-stimulating factor for dapsone-induced agranulocytosis in leukocytoclastic vasculitis.
    Miyagawa S; Shiomi Y; Fukumoto T; Ishii Y; Shirai T
    J Am Acad Dermatol; 1993 Apr; 28(4):659-61. PubMed ID: 7681858
    [No Abstract]   [Full Text] [Related]  

  • 3. A Case of Erythema Elevatum Diutinum With Pancytopenia: Focus on Dapsone-Induced Hematologic Side Effects and Colchicine as a Safe Treatment Option.
    Kocatürk E; Memet B; Topal IO; Yüksel T; Ülkümen PK; Kızıltaç U
    J Drugs Dermatol; 2015 Oct; 14(10):1090-2. PubMed ID: 26461818
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal hypersensitivity vasculitis associated with dapsone.
    Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Rabel-Filho OC; Martini-Filho D; Fontes CJ
    Am J Kidney Dis; 2005 Oct; 46(4):e51-3. PubMed ID: 16183407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annular leucocytoclastic vasculitis: response to dapsone.
    Ruiz Villaverde R; Blasco Melguizo J; Martin Sanchez MC; Naranjo Sintes R
    J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):544-6. PubMed ID: 12428865
    [No Abstract]   [Full Text] [Related]  

  • 6. Dapsone-induced agranulocytosis-possible involvement of low-activity N-acetyltransferase 2.
    Potočnjak I; Likić R; Šimić I; Juričić Nahal D; Čegec I; Ganoci L; Božina N
    Fundam Clin Pharmacol; 2017 Oct; 31(5):580-586. PubMed ID: 28322460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous vasculitis with partial C4 deficiency responsive to dapsone.
    Lilic D; Carmichael AJ
    Br J Dermatol; 1997 Sep; 137(3):476. PubMed ID: 9349359
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic effects of pentoxifylline and dapsone in leucocytoclastic vasculitis.
    Nürnberg W; Grabbe J; Czarnetzki BM
    Lancet; 1994 Feb; 343(8895):491. PubMed ID: 7906000
    [No Abstract]   [Full Text] [Related]  

  • 9. Alternative procedure to allow continuation of dapsone therapy despite serious adverse reaction in a case of dapsone-sensitive erythema elevatum diutinum.
    Seneschal J; Guillet S; Ezzedine K; Taïeb A; Milpied B
    Dermatology; 2012; 224(2):115-9. PubMed ID: 22508198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Falsely decreased HbA1c in a type 2 diabetic patient treated with dapsone.
    Lai YC; Wang CS; Wang YC; Hsu YL; Chuang LM
    J Formos Med Assoc; 2012 Feb; 111(2):109-12. PubMed ID: 22370290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
    Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone in allergic vasculitis: its use in Henoch-Schönlein disease following vaccination.
    Ledermann JA; Hoffbrand BI
    J R Soc Med; 1983 Jul; 76(7):613-4. PubMed ID: 6876052
    [No Abstract]   [Full Text] [Related]  

  • 13. Sustained dapsone-induced remission of hypocomplementemic urticarial vasculitis--a case report.
    Eiser AR; Singh P; Shanies HM
    Angiology; 1997 Nov; 48(11):1019-22. PubMed ID: 9373057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypocomplementemic vasculitis treated with dapsone].
    Hérault M; Mazet J; Beurey P; Cuny JF; Barbaud A; Schmutz JL; Bursztejn AC
    Ann Dermatol Venereol; 2010; 137(8-9):541-5. PubMed ID: 20804899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988.
    Hörnsten P; Keisu M; Wiholm BE
    Arch Dermatol; 1990 Jul; 126(7):919-22. PubMed ID: 2360840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone-induced haemolytic anaemia and agranulocytosis in a patient with normal glucose-6-phosphate-dehydrogenase activity.
    Figueiredo MS; Pinto BO; Zago MA
    Acta Haematol; 1989; 82(3):144-5. PubMed ID: 2510435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agranulocytosis during dapsone administration.
    Ten Broeke JE; Cunningham LD
    Dermatologica; 1973; 146(1):21-4. PubMed ID: 4694139
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel use of topical dapsone 5% gel for erythema elevatum diutinum: safer and effective.
    Frieling GW; Williams NL; Lim SJ; Rosenthal SI
    J Drugs Dermatol; 2013 Apr; 12(4):481-4. PubMed ID: 23652900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urticaria vasculitis and sulfone, a case report].
    Wozel G; Thiele B
    Z Hautkr; 1987 Mar; 62(5):407-9. PubMed ID: 3590913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent annular erythema with purpura: a new variant of leucocytoclastic vasculitis responsive to dapsone.
    Cribier B; Cuny JF; Schubert B; Colson A; Truchetet F; Grosshans E
    Br J Dermatol; 1996 Dec; 135(6):972-5. PubMed ID: 8977722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.